Epidemiology & Risk Factors

  • Bimodal distribution: Infancy (first 3 mos, self-limiting) and Adulthood (30-60 yo; predilection for males).
  • Associated conditions (High-Yield NBME triggers):
    • Parkinson disease and other neuro conditions (e.g., stroke, TBI).
    • HIV infection (severe, sudden-onset, widespread, or refractory presentation warrants HIV screening).
  • Pathophysiology: Inflammatory response to commensal Malassezia species (lipophilic yeast) in areas of high sebaceous gland density; non-contagious.

Clinical Features

  • Infants:
    • “Cradle cap”: Non-pruritic, asymptomatic, thick, greasy, yellowish scales over the scalp vertex.
    • May involve diaper area, face, and intertriginous neck folds (erythema with greasy maceration; typically spares groin creases).
  • Adults:
    • Erythematous patches/plaques with greasy, yellowish, oily scales or fine, white, dry flaking (dandruff/pityriasis capitis).
    • Distribution: Sebum-rich areas:
      • Scalp, hairline, and external auditory canal.
      • Nasolabial folds, glabella, eyebrows, and beard area.
      • Presternal area and upper back.
    • Symptoms: Mild-to-moderate pruritus, burning, worsened during cold/dry weather or periods of emotional/physical stress.

Diagnosis

  • Initial/Screening: Clinical diagnosis based on characteristic appearance and anatomical distribution.
  • Key Labs:
    • None routinely indicated.
    • HIV 4th-gen Ag/Ab combo assay: Indicated if lesions are atypical, explosive in onset, severe, or treatment-refractory.
  • Confirmatory/Gold Standard: Clinical; skin biopsy rarely required (shows hyperkeratosis, parakeratosis around follicles, and spongiosis).
  • Ancillary:
    • KOH preparation: Performed to rule out dermatophyte infections (e.g., tinea); negative for branching pseudohyphae/hyphae characteristic of dermatophytosis.

Differential Diagnostics

  • Psoriasis:
    • Diff by well-demarcated plaques with thick, silvery-white (micaceous) scales, Auspitz sign (pinpoint bleeding upon scraping scale), extensor distribution (elbows, knees), and nail pitting.
  • Atopic Dermatitis:
    • Diff by severe, intractable pruritus, predilection for flexural creases (antecubital/popliteal fossae in adults/older kids) vs cheeks/extensors in infants (spares diaper area), and strong personal/atopic family history.
  • Tinea Capitis:
    • Diff by localized scaly patches with alopecia, “black dots” (broken hair shafts), and cervical/postauricular lymphadenopathy; (+) KOH mount for branching fungal hyphae.
  • Rosacea:
    • Diff by persistent central facial erythema, flushing provoked by hot liquids/spicy food/alcohol, telangiectasias, and papulopustules without comedones or greasy scaling.
  • Langerhans Cell Histiocytosis:
    • Diff in infants by refractory, weeping, purpuric/petechial scalp and diaper rash associated with systemic signs (lytic bone lesions, hepatosplenomegaly, failure to thrive).

Management

  • Infants (“Cradle Cap”):
    • First-line (Conservative): Emollients (mineral oil, petroleum jelly, baby oil) to soften crusts, followed by gentle massage with a soft brush and non-medicated baby shampoo.
    • Second-line/Refractory: Short course of low-potency topical hydrocortisone 1% or ketoconazole 2% cream/shampoo.
  • Adults (Scalp):
    • First-line: Topical antifungals: Ketoconazole 2% shampoo, selenium sulfide, zinc pyrithione, or tar-based shampoos (used 2-3x/week).
    • Second-line/Acute Flare: Intermittent, short-term low-to-medium potency topical corticosteroids (e.g., fluocinolone, betamethasone lotion) to control pruritus and erythema.
  • Adults (Face & Intertriginous Areas):
    • First-line: Low-potency topical antifungal (ketoconazole 2% cream).
    • Alternative/Second-line: Low-potency topical corticosteroids (hydrocortisone 1-2.5%) short-term or topical calcineurin inhibitors (tacrolimus, pimecrolimus) to avoid steroid-induced facial skin atrophy/rosacea.
  • Refractory Cases:
    • Screen for underlying HIV or neurodegenerative disease.
    • Oral antifungals (e.g., itraconazole) rarely used for extensive, recalcitrant disease.

Complications

  • Secondary bacterial infection: Impetiginization typically caused by Staphylococcus aureus or Streptococcus pyogenes (honey-colored crusting).
  • Blepharitis/meibomian gland dysfunction (crusting along eyelid margins).
  • Psychological and cosmetic distress.